SAVIENT PHARMACEUTICALS INC: accounts_receivable
| Value | {"amount": 6819000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-09-30) |
| Status | current |
| Entity | SAVIENT PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4e46b748-44d1-496a-95f9-107dba723bfb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-442309 · Open the official SEC filing →Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000722104/accounts-receivable/2013-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4e46b748-44d1-496a-95f9-107dba723bfb
History
- no predecessors — first report